Table 2.
Subject characteristics (Study 2)
| Variable | YG (n=15) | MA/O (n=14) | P-value |
|---|---|---|---|
| Age, years | 26 ± 2 | 57 ± 2 | <0.001 |
| Women/Men (%) | 40/60 | 57/43 | 0.687 |
| BMI, kg·m2 | 24 ± 1 | 23 ± 1 | 0.333 |
| Waist/hip ratio | 0.79 ± 0.02 | 0.82 ± 0.03 | 0.304 |
| Triglycerides, mg·dL−1 | 65 ± 8 | 67 ± 5 | 0.122 |
| LDL, mg·dL−1 | 93 ± 6 | 89 ± 6 | 0.698 |
| HDL, mg·dL−1 | 53 ± 4 | 68 ± 5 | 0.029 |
| Total cholesterol, mg·dL−1 | 169 ± 11 | 171 ± 5 | 0.909 |
| Ambulatory BP | |||
| 24-hr systolic BP, mmHg | 123 ± 2 | 116 ± 2 | 0.042 |
| 24-hr diastolic BP, mmHg | 72 ± 2 | 72 ± 2 | 0.781 |
| 24-hr mean BP, mmHg | 89 ± 2 | 86 ± 2 | 0.210 |
| Arterial stiffness | |||
| Carotid-femoral PWV, m·s−1 | 5.8 ± 0.2 | 7.8 ± 0.5 | 0.001 |
| Carotid CC, mm2·mmHg−1 | 0.14 ± 0.01 | 0.10 ± 0.01 | 0.005 |
| Carotid-brachial PWV, m·s−1 | 6.1 ± 0.2 | 7.8 ± 0.5 | 0.002 |
| History | |||
| HTN or borderline HTN, n (%) | 1 (7) | 0 (0) | -- |
| Family HTN, n (%) | 7 (47) | 5 (43) | 0.938 |
| Smoking, n (%) | 2 (20) | 3 (21) | 0.894 |
| Cardiovascular medications | |||
| Statin, n (%) | 0 (0) | 0 (0) | -- |
| Diuretic, n (%) | 0 (0) | 0 (0) | -- |
| ACE inhibitor, n (%) | 0 (0) | 0 (0) | -- |
Values are means ± SE. YG, young adults; MA/O, middle-age/older adults BMI, body mass index; LDL and HDL, low/high density lipoprotein; BP, blood pressure; PWV, pulse wave velocity; CC, compliance coefficient; HTN, hypertension.